Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Genetic Modification of T Cells.

Morgan RA, Boyerinas B.

Biomedicines. 2016 Apr 20;4(2). pii: E9. doi: 10.3390/biomedicines4020009. Review.

2.

Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells.

Boyerinas B, Jochems C, Fantini M, Heery CR, Gulley JL, Tsang KY, Schlom J.

Cancer Immunol Res. 2015 Oct;3(10):1148-1157. doi: 10.1158/2326-6066.CIR-15-0059. Epub 2015 May 26.

3.

Reversible metal-hydride phase transformation in epitaxial films.

Roytburd AL, Boyerinas BM, Bruck HA.

J Phys Condens Matter. 2015 Mar 11;27(9):092201. doi: 10.1088/0953-8984/27/9/092201. Epub 2015 Feb 11.

PMID:
25671335
4.

Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.

Tucker JA, Jochems C, Boyerinas B, Fallon J, Greiner JW, Palena C, Rodell TC, Schlom J, Tsang KY.

Cancer Immunol Immunother. 2014 Dec;63(12):1307-17. doi: 10.1007/s00262-014-1603-2. Epub 2014 Sep 4.

5.

Formation of self-assembled nanoplates via hydrogenation of epitaxial Pd film.

Boyerinas BM, Roytburd AL, Bruck HA.

Nano Lett. 2014;14(4):1818-22. doi: 10.1021/nl404410v. Epub 2014 Mar 12.

PMID:
24588220
6.

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein.

Jochems C, Tucker JA, Vergati M, Boyerinas B, Gulley JL, Schlom J, Tsang KY.

Cancer Immunol Immunother. 2014 Feb;63(2):161-74. Epub 2013 Nov 15.

7.

Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.

Boyerinas B, Zafrir M, Yesilkanal AE, Price TT, Hyjek EM, Sipkins DA.

Blood. 2013 Jun 13;121(24):4821-31. doi: 10.1182/blood-2012-12-475483. Epub 2013 Apr 15.

8.

Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1.

Boyerinas B, Park SM, Murmann AE, Gwin K, Montag AG, Zillhardt M, Hua YJ, Lengyel E, Peter ME.

Int J Cancer. 2012 Apr 15;130(8):1787-97. doi: 10.1002/ijc.26190. Epub 2011 Aug 16.

9.

HSPCs in the balance: The vascular niche.

Boyerinas B, Sipkins DA.

Cell Stem Cell. 2010 Dec 3;7(6):645-6. doi: 10.1016/j.stem.2010.11.021. No abstract available.

10.

The role of let-7 in cell differentiation and cancer.

Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME.

Endocr Relat Cancer. 2010 Jan 29;17(1):F19-36. doi: 10.1677/ERC-09-0184. Print 2010 Mar. Review.

PMID:
19779035
11.

MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death.

Schickel R, Boyerinas B, Park SM, Peter ME.

Oncogene. 2008 Oct 6;27(45):5959-74. doi: 10.1038/onc.2008.274. Review.

PMID:
18836476
12.

Identification of let-7-regulated oncofetal genes.

Boyerinas B, Park SM, Shomron N, Hedegaard MM, Vinther J, Andersen JS, Feig C, Xu J, Burge CB, Peter ME.

Cancer Res. 2008 Apr 15;68(8):2587-91. doi: 10.1158/0008-5472.CAN-08-0264.

13.

Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.

Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B, Dinulescu DM, Lengyel E, Peter ME.

Cell Cycle. 2007 Nov 1;6(21):2585-90. Epub 2007 Aug 6.

PMID:
17957144
14.

Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities.

Alappat EC, Feig C, Boyerinas B, Volkland J, Samuels M, Murmann AE, Thorburn A, Kidd VJ, Slaughter CA, Osborn SL, Winoto A, Tang WJ, Peter ME.

Mol Cell. 2005 Aug 5;19(3):321-32.

Supplemental Content

Loading ...
Support Center